Orchid Pharma Ltd

ORCHPHARMA

Company Profile

  • Business description

    Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment, which is Pharmaceuticals, in which the company derives its maximum sales through Active Pharmaceutical Ingredients. It produces various products such as tablets, injectables, and APIs for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotic, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. Geographically, the company generates maximum revenue from the export of its products to international markets like the United States, Canada, Europe, Japan, Australia, and China etc., and the rest from its business in India.

  • Contact

    Sector 74A
    15th Floor, Tower-1, DLF Corporate Greens
    Narsinghpur
    GurugramHR122004
    IND

    T: +91 4428211000

    E: [email protected]

    https://www.orchidpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    1,051

Stocks News & Analysis

stocks

ASX major bank drives strong quarterly profit

Profit momentum remains robust yet shares overvalued.
stocks

Ask the analyst: What to expect in earnings season?

The key metrics that matter this earnings season.
stocks

ASX healthcare share remains undervalued ahead of earnings

Margin recovery remains the key driver for this ASX healthcare share.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,041.5013.900.15%
CAC 408,372.280.000.00%
DAX 4025,099.00335.881.36%
Dow JONES (US)51,947.25235.600.46%
FTSE 10010,736.2397.060.91%
HKSE25,166.58203.350.81%
NASDAQ24,975.82161.87-0.64%
Nikkei 22564,551.9059.25-0.09%
NZX 50 Index13,812.5240.230.29%
S&P 5007,411.983.680.05%
S&P/ASX 2008,872.9015.000.17%
SSE Composite Index3,829.3915.190.40%

Market Movers